Status:

COMPLETED

A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's Disease

Lead Sponsor:

Janssen Research & Development, LLC

Conditions:

Healthy

Alzheimer Disease

Eligibility:

All Genders

50-90 years

Phase:

EARLY_PHASE1

Brief Summary

The purpose of this study is to investigate changes of cerebral spinal fluid (CSF) proteins over time using continuous CSF sampling for 36 hours in elderly healthy volunteers and volunteers with mild ...

Detailed Description

This is a study to measure specific proteins in the cerebral spinal fluid (CSF) of healthy elderly volunteers and volunteers with mild cognitive impairment (MCI) or Alzheimer's Disease (AD). No invest...

Eligibility Criteria

Inclusion

  • Healthy elderly Volunteers (Part A: age range 55 to 85 years of age, inclusive) and Volunteers with AD or MCI and a typical AD biomarker signature (Part B: age range 50 to 90 years of age, inclusive), with a body mass index (BMI) between 18 and 35 kg/m2 (inclusive) who satisfy the additional inclusion criteria specified in the study protocol will be eligible for enrollment in this study

Exclusion

  • Has a clinically significant abnormal physical or neurological examination (including fundoscopy), vital signs or 12-lead electrocardiogram (ECG) at screening
  • Has a relevant history of lower back pain or scoliosis and/or major (lumbar) back surgery (microdiscectomy is allowed)
  • Has a history of spontaneous, prolonged or severe bleeding with unclear origin
  • Has a history of epilepsy or fits or unexplained black-out
  • has any other exclusion criteria as specified in the study protocol

Key Trial Info

Start Date :

September 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2013

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT01436188

Start Date

September 1 2011

End Date

June 1 2013

Last Update

March 18 2014

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Antwerp, Belgium

2

Groningen, Netherlands

3

Leiden, Netherlands